ISO 10993-7:2026

Overview

ISO 10993-7:2026 is an international standard developed by ISO for the biological evaluation of medical devices, focusing specifically on Part 7: Ethylene oxide sterilization residuals. This standard sets forth the allowable limits for residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in medical devices that have been sterilized using EO. It also describes the methods for measuring EO and ECH residuals, as well as procedures for determining conformity and safely releasing products to the market. Devices or components without direct or indirect body or user contact, such as in vitro diagnostic devices, are outside the scope of this standard. Additionally, medical devices made only of materials like glass or metal that do not retain EO or ECH are not covered by this document.

ISO 10993-7:2026 is a critical resource for medical device manufacturers, regulatory professionals, and quality assurance teams to ensure products are both safe and compliant with international health standards regarding sterilant residues.

Key Topics

• Allowable Limits (AL) for EO and ECH: The standard defines maximum permissible residual amounts of EO and ECH on medical devices for different durations of patient exposure, categorizing devices as limited, prolonged, or long-term exposure.
• Measurement and Extraction Procedures: Procedures for simulated-use and exhaustive extraction methods are included to evaluate residuals under clinically relevant conditions.
• Risk Assessment: An approach for toxicological risk assessment is included, allowing adjustment of allowable limits based on device type, patient population, and specific clinical scenarios.
• Conformity Assessment: Outlines methods for demonstrating that a device meets allowable residual limits before market release, including required documentation and calculation examples.
• Biological Safety Considerations: Integrates biological evaluation under ISO 10993-1 to justify that EO-sterilized devices are safe for intended use durations.
• Comprehensive Guidance: Annexes provide detailed background, rationale, calculation methods, flowcharts, and additional guidance for users to interpret and implement the standard consistently.

Applications

ISO 10993-7:2026 is widely applied in the medical device industry to establish safe levels of ethylene oxide and its by-products after sterilization. Key applications include:

• Release of EO-Sterilized Medical Devices: Ensures that products intended for direct or indirect body contact do not pose health risks due to residual EO or ECH.
• Sterilization Process Validation: Guides manufacturers in setting and validating sterilization and aeration parameters based on residual risk assessment and extraction testing.
• Regulatory Submissions: Used to demonstrate compliance with international safety standards for EO sterilization residuals in regulatory filings for device approval.
• Risk Management: Assists manufacturers in conducting risk assessments considering duration of exposure, patient demographic, and cumulative exposure from multiple devices.
• Quality Assurance Programs: Integrates seamlessly into quality management systems, ensuring repeatable, documentable safety assessments for each batch or device type.

Related Standards

Several ISO standards are closely related to ISO 10993-7:2026 and are often referenced or used in conjunction:

• ISO 10993-1:2025 – Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.
• ISO 10993-17:2023 – Establishes toxicological risk assessment practices for leachables and extractables from medical devices.
• ISO 10993-18:2020 – Focuses on chemical characterization of medical device materials.
• ISO 10993-23:2021 – Specifies tests for irritation to ensure local tissue compatibility.
• ISO 11135 – Covers requirements for the validation and routine control of EO sterilization.

By following ISO 10993-7:2026, medical device organizations can ensure compliant, patient-safe products and reinforce trust in their sterilization processes while meeting international regulatory expectations regarding ethylene oxide sterilization residuals.